June 23, 2026 

　Dr. Masato Murakami, President and Representative Director of the Company, has been appointed President of the Japan Radiopharmaceuticals Association(JRPA), effective June 19, 2026.

　The Japan Radiopharmaceuticals Association is an industry organization that supports pharmaceutical companies handling radiopharmaceuticals through activities such as promoting the safe handling of radiopharmaceuticals and ensuring safety during transportation.
　Through its participation in the Association's activities, the Company will contribute to the development of the industry while continuing its efforts to ensure a stable supply of radiopharmaceuticals and contribute to healthcare.